These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9526190)

  • 1. Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance.
    Lipsitch M; Levin BR
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):187-99. PubMed ID: 9526190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling.
    Gumbo T; Louie A; Deziel MR; Parsons LM; Salfinger M; Drusano GL
    J Infect Dis; 2004 Nov; 190(9):1642-51. PubMed ID: 15478070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Within-host population dynamics of antibiotic-resistant M. tuberculosis.
    Alavez-Ramírez J; Castellanos JR; Esteva L; Flores JA; Fuentes-Allen JL; García-Ramos G; Gómez G; López-Estrada J
    Math Med Biol; 2007 Mar; 24(1):35-56. PubMed ID: 17060491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistance of Mycobacterium tuberculosis in time.
    Mazzei L; Croce GF; Zarzana A; Biagioli D; Sposato B; Pulcinelli A
    Eur Rev Med Pharmacol Sci; 1998; 2(1):21-4. PubMed ID: 9825566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
    Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
    J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-resistant tuberculosis in Taipei, 1996-1999.
    Wang PD; Lin RS
    Am J Infect Control; 2001 Feb; 29(1):41-7. PubMed ID: 11172317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
    Shenai S; Rodrigues C; Mehta A
    Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.
    Gumbo T; Louie A; Liu W; Brown D; Ambrose PG; Bhavnani SM; Drusano GL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2329-36. PubMed ID: 17438043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the resistance ratio and proportion methods for antimicrobial susceptibility testing of Mycobacterium tuberculosis.
    Tansuphasiri U; Subpaiboon S; Rienthong S
    J Med Assoc Thai; 2001 Oct; 84(10):1467-76. PubMed ID: 11804258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug resistance of Mycobacterium tuberculosis in a nationwide epidemiological survey in China in the year of 2000].
    Liu Y; Jiang G; Zhao L; Fu Y; Li Y; Bi Z; Wang S
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Apr; 25(4):224-7. PubMed ID: 12133331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of Mycobacterium tuberculosis drug resistance in New Caledonia, 1995-1996.
    Duval P; Levenes H; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):219-23. PubMed ID: 10094323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of drug resistance in tuberculosis.
    Riska PF; Jacobs WR; Alland D
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S4-10. PubMed ID: 10688142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the molecular mechanism of multi-drug resistance in clinical isolates of Mycobacterium tuberculosis].
    Wu X; Zhuang Y; Zhang J
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):332-5. PubMed ID: 10374440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug resistance of Mycobacterium tuberculosis in Orizaba, Veracruz. Implications for the tuberculosis prevention and control program].
    García-García ML; Sifuentes-Osornio J; Jiménez-Corona ME; Ponce-de-León A; Jiménez-Corona A; Bobadilla-del Valle M; Palacios-Martínez M; Canales G; Sanginés A; Jaramillo Y; Martínez-Gamboa A; Balandrano S; Valdespino-Gómez JL; Small P
    Rev Invest Clin; 2001; 53(4):315-23. PubMed ID: 11599478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug resistance in Mycobacterium tuberculosis: diagnostic methods].
    Loïez-Durocher C; Vachée A; Lemaitre N
    Ann Biol Clin (Paris); 2000; 58(3):291-7. PubMed ID: 10846233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.